Title of report: second primary ovarian carcinomas after breast cancer diagnosis- an analysis of a single cancer centre in China

Title of report: second primary ovarian carcinomas after breast cancer diagnosis- an analysis of a single cancer centre in China

ObjectiveWe aimed to evaluate the clinicopathological characteristics and survival outcomes of patients with second primary ovarian carcinomas after a breast cancer diagnosis.Materials and methodsWe reviewed the medical reports of 23 patients at Sichuan Cancer Hospital between May 2002 and October 2...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hong Liu, Min Luo, Chunrong Peng, Xinghan Cheng, Gupo Luo, Dengfeng Wang, Guonan Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-06-01
Series:	Frontiers in Oncology
Subjects:	double primary malignancy breast cancer ovarian cancer interval between diagnoses survival outcome
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1553366/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Predictive Value of the CA-125 Elimination Rate Constant K (KELIM) in Predicting Progression-Free Survival and Overall Survival in Epithelial Ovarian Cancer
by: Necim Yalcin, et al.
Published: (2025-07-01)

Neoadjuvant chemotherapy in advanced epithelial ovarian cancer: A survival study
by: Upasana Baruah, et al.
Published: (2015-01-01)

Clinical efficacy analysis of chemotherapy of isolated neck lymphatic metastasis in advanced epithelial ovarian cancer
by: Hong Liu, et al.
Published: (2025-05-01)

Clinical characteristics and survival of breast cancer patients with extramammary malignancies in a single Asian center over the past 23 years
by: Bei Sun, et al.
Published: (2025-05-01)

Modern clinical portrait of ovarian cancer patient in the Novosibirsk region
by: A. V. Tarkhov, et al.
Published: (2025-03-01)

Hypo- and hyperthyroidism and survival of ovarian cancer patients
by: I. V. Sobolev, et al.
Published: (2020-03-01)

Primary versus interval debulking surgery in the management of ovarian cancer patients, current data summary
by: Victoria Psomiadou, et al.
Published: (2022-04-01)

Recurrent ovarian cancer: prolongation of the platinum-free interval with the use of a weekly treatment regimen of hycamtin (topotecan)
by: E. G. Novikova, et al.
Published: (2014-07-01)

Malignant ascites in ovarian cancer is compatible with long-term (10 year) survival with associations to clinicopathological features
by: Lok Hang Chow, et al.
Published: (2025-05-01)

HIPEC after Interval Debulking Surgery as Best Clinical Practice in Ovarian Cancer Patients: Case Series and Literature Review
by: Stefano Restaino, et al.
Published: (2022-06-01)

Protein expression profiling identifies a prognostic model for ovarian cancer
by: Luyang Xiong, et al.
Published: (2022-07-01)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014-07-01)

Low Serum Cholinesterase Levels Predict Poor Prognosis in Patients with Ovarian Cancer
by: Su H, et al.
Published: (2025-02-01)

A rare case of synchronous multiple primary malignancies of breast cancer and diffuse large B-cell lymphoma that responded to multidisciplinary treatment: a case report
by: Yuichi Ueda, et al.
Published: (2022-05-01)

The effect of waiting time on ovarian cancer survival in oncology centres, Addis Ababa, Ethiopia: a retrospective cohort study
by: Abrham Tesfaye Habteyes, et al.
Published: (2025-01-01)

Estimating long-term overall survival with olaparib as maintenance therapy in patients with newly diagnosed advanced ovarian cancer with BRCA mutations
by: N. A. Avxentyev, et al.
Published: (2021-10-01)

The impact of multiple neoadjuvant chemotherapy cycles in patients with advanced epithelial ovarian cancer: A single center experience
by: Wala Mehros, et al.
Published: (2025-01-01)

Current Status and Controversies in Neoadjuvant Chemotherapy for Advanced Stage Ovarian Cancer: A Review
by: Jiaxi Li, et al.
Published: (2023-11-01)

Development and validation of nomograms to forecast overall survival and cancer-specific survival in Asian patients diagnosed with epithelial ovarian cancer
by: Hao He, et al.
Published: (2025-03-01)

The effect of postoperative chemotherapy on blood glucose and prognosis in patients with advanced ovarian cancer
by: Ting Du, et al.
Published: (2025-01-01)

The Effect of Neutrophil-to-Lymphocyte Ratio on Prognosis in Malignant Ovarian Germ Cell Tumors
by: Yagmur Arslan, et al.
Published: (2025-04-01)

A CT-based radiomics model for predicting progression-free survival in patients with epithelial ovarian cancer
by: Yinping Leng, et al.
Published: (2025-05-01)

Survival Analysis of Ovarian Cancer Patients in Yazd City, Central part of Iran, 1999-2018
by: Maryam Arabi, et al.
Published: (2024-01-01)

Hyperthermic intraperitoneal chemotherapy after upfront cytoreductive surgery for stage III epithelial ovarian cancer: Follow‐up of long‐term survival
by: Ziying Lei, et al.
Published: (2025-05-01)

Analysis of early diagnostic pathway for prostate cancer in Slovenia
by: Kokot Mateja Kokalj, et al.
Published: (2024-10-01)

Decoding the pathological and genomic profile of epithelial ovarian cancer
by: Rim Rejaibi, et al.
Published: (2024-11-01)

Primary cytoreductive surgery followed by chemotherapy compared to neoadjuvant chemotherapy followed by cytoreduction as a treatment for stage III and IV ovarian cancer (literature review)
by: E. V. Sibirskaya, et al.
Published: (2024-05-01)

Multiple primary malignancies of female genital organs: ways of prevention
by: Yu. G. Payanidi, et al.
Published: (2014-08-01)

CHANGES IN VALUES OF MEAN AGE IN PATIENTS WITH PRIMARY DIAGNOSED MALIGNANCIES I N KRASNODAR REGION IN 2001-2015
by: R. A. Murashko, et al.
Published: (2019-02-01)

The Role of Initial Neutropenia and Neutrophil Dynamics in Personalizing Chemotherapy for Platinum-Resistant Ovarian Cancer
by: Radu-Dumitru Dragomir, et al.
Published: (2025-03-01)

The application of risk models based on machine learning to predict endometriosis‐associated ovarian cancer in patients with endometriosis
by: Xiaopei Chao, et al.
Published: (2022-12-01)

Intraperitoneal biotherapy of malignant peritoneal effusions in ovarian cancer patients
by: К. S. Titov, et al.
Published: (2014-07-01)

Particulate matter and their interaction of physical activity on ovarian cancer survival: A prospective cohort study
by: Ying-Ying Zhang, et al.
Published: (2025-06-01)

The impact of the COVID-19 pandemic on the diagnosis, treatment, and prognosis of ovarian cancer in the United States: a retrospective cohort study based on the SEER database
by: Yuqin Wang, et al.
Published: (2025-04-01)

Residual tumor and primary debulking surgery vs interval debulking surgery in stage IV epithelial ovarian cancer
by: Sarah Mejer Sørensen, et al.
Published: (2022-03-01)

A clinical case of synchronous endometrial and ovarian cancer associated with pregnancy
by: A. L. Chernyshova, et al.
Published: (2023-08-01)

Deep learning based on ultrasound images to predict platinum resistance in patients with epithelial ovarian cancer
by: Chang Su, et al.
Published: (2025-05-01)

Factors in malignant transformation of ovarian endometriosis: A narrative review
by: Andrea Giannini, et al.
Published: (2024-12-01)

Dimensionality cutback and deep learning algorithms efficacy as to the breast cancer diagnostic dataset
by: Gennady Chuiko, et al.
Published: (2024-11-01)

Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
by: Zihan Li, et al.
Published: (2025-07-01)